Our Faculty
Flavio Guzmán, M.D.
Publications of Flavio Guzmán, M.D.
Venlafaxine Guide: Pharmacology, Indications, Dosing Guidelines and Adverse Effects
0.50 CMEs
This guide covers pharmacodynamics, pharmacokinetics, dosage forms, indications, side effects, and use in special populations. It also discusses venlafaxine's mechanism of action, metabolism, and FDA-approved and off-label uses.
Fluvoxamine Practical Guide: Pharmacology, Indications, Dosing Guidelines, and Adverse Effects
0.50 CMEs
Fluvoxamine (Luvox) is approved for OCD in both pediatric and adult patients in the U.S. There is no definitive evidence suggesting it is more effective than other SSRIs for OCD. It is also approved for depression in the UK. Fluvoxamine is an inhibitor of CYP1A2 and should not be combined with MAOIs.
Citalopram and Escitalopram: A Summary of Key Differences and Similarities
0.50 CMEs
This article provides an in-depth comparison of citalopram and escitalopram, covering their chemical composition, pharmacokinetics, FDA-approved indications, off-label uses, potential side effects, and the risk of QT prolongation associated with both drugs. Furthermore, it addresses crucial considerations for prescribing these medications to specific patient populations.
Fluoxetine Practical Guide: Pharmacology, Indications, Dosing Guidelines and Adverse Effects
0.50 CMEs
Fluoxetine is a potent serotonin reuptake inhibitor with a long half-life. It is FDA-approved for depression, OCD, panic disorder and bulimia. Fluoxetine also has off-label uses like treating repetitive behaviors in autism. This guide covers fluoxetine's pharmacology, dosing, side effects and use in special populations.
February 2020 Newsletter: Lumateperone, Unipolar Depression, Natural Medications, and More
No Credits
In this issue, we discuss psychopharmacology news and recap our most useful key points from recent CME activities. We share recent information on lumateperone, key points from a presentation on unipolar depression, an expert interview on natural medications, and our research reviews (Quick Takes).
2019 in Review: New Drugs, Indications, and Formulations
No Credits
This summary is a quick guide for clinicians on 2019 U.S. Food and Drug Administration (FDA) approvals.
Psychopharmacology Journals and Resources
No Credits
Adverse Effects of SSRIs
No Credits
This video is an introduction to the adverse effects of SSRIs.
2018 APA Alcohol Use Disorder Guideline: Summary of Recommendations
No Credits
The American Psychiatric Association (APA) released practice guidelines on the treatment of alcohol use disorder.
We reproduce below a summary of selected recommendations on pharmacotherapy.
Antidepressants and Weight Change: An Evidence-Based Tool
No Credits
Bipolar Disorder Treatment Guidelines: A 2018 Update
No Credits
This page offers direct links to the most recent guidelines for the treatment of bipolar disorder.
Psychopharmacology Highlights from the 2018 APA Annual Meeting
No Credits
This update summarizes algorithms for adult ADHD and MDD, use of psychotropic medications in breastfeeding, the role of pharmacogenetic testing in clinical practice and an immunotherapy approach to schizophrenia treatment.
1
…